ArticleOncoimmunology2021

Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival.

Fiamma Berner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.